ShockWave Medical Inc buy BiotechBee
Start price
07.09.22
/
70%
€285.40
Target price
31.12.25
€400.00
Performance (%)
-47.00%
End price
12.11.23
€151.25
Summary
This prediction ended on 12.11.23 with a price of €151.25. Massive losses of -47.00% were the result for the BUY prediction by BiotechBee. BiotechBee has 70% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| ShockWave Medical Inc | - | - | - | - |
| iShares Core DAX® | 1,60 % | -7,45 % | 3,04 % | 46,26 % |
| iShares Nasdaq 100 | -0,73 % | -1,86 % | 15,42 % | 72,33 % |
| iShares Nikkei 225® | 1,30 % | -6,80 % | 34,31 % | 52,28 % |
| iShares S&P 500 | -0,39 % | -2,34 % | 9,91 % | 55,10 % |
According to BiotechBee what are the pros and cons of ShockWave Medical Inc for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread ShockWave Medical Inc diskutieren
Buy mit Kursziel 400,0